DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 03 · Volume 33 · 1975 DOI: 10.1055/s-009-45085

Editorial

National Conference on Thrombosis and Hemostasis, Dallas, Texas, 20.—22. November 1974

405
James Day, H; Mosesson, Michael W: Introduction
426
Nossel, Hymie L; Butler, Vincent P; Canfield, Robert E; Yudelman, Ian; Ti, Mary; Spanondis, Kalliope; Soland, Tove: Potential Use of Fibrinopeptide A Measurements in the Diagnosis and Management of Thrombosis
464
Sasahara, Arthur A; Bell, William R; Simon, Toby L; Stengle, James M; Sherry, Sol: The Phase II Urokinase-Streptokinase Pulmonary Embolism Trial

Original Article

553
Østerud, B; Laake, K; Prydz, H: The Activation of Human Factor IX

International Committee on Thrombosis and Haemostasis Task Force

600
617
Kingdon, H. S; Lundblad, R. L; Veltkamp, J. J; Aronson, D. L: Potentially Thrombogenic Materials in Factor IX Concentrates
632
Cash, John D; Dalton, Rodger G; Middleton, Sarah; Smith, James K: Studies on the Thrombogenicity of Scottish Factor IX Concentrates in Dogs

International Committee on Thrombosis and Haemostasis Basel, 8.—11. September 1974 Subcommittee on Clinical Investigations

Letter to the Editor

664
Coeugniet, E. G; Søeberg, B: Dipyridamole
666
Loeliger, E. A; Boekhout-Mussert, M. J; Bieger, R: Prolonged Continuous Heparin Treatment
667
Dijk-Wierda, C. A. v; Loeliger, E. A: External Quality Control in The Netherlands
674
de Jonge, H; Loeliger, E. A: Action of Sulfinpyrazon